Methods of treating measles infectious disease in mammals

The invention provides for a measles vaccine utilizing a human codon-optimized polynucleotide encoding a measles virus polypeptide, such as HA or F protein. Optionally, the vaccine is administered with an adjuvant and is especially useful for immunizing an infant mammal.

Attached files:
2461832.jpg

Patents:
GB 2,461,832

Inventor(s): VILALTA ADRIAN [US]; JIMENEZ GRETCHEN [US]; GRIFFIN DIANE E [US]

Type of Offer: Licensing

Contact Patent Owner or Broker


Next Patent »
« More Biotech Patents

Share on      

CrowdSell Your Patent